[EN] COMPOSITIONS FOR THE TREATMENT OF FIBROSIS AND FIBROSIS-RELATED CONDITIONS [FR] COMPOSITIONS POUR LE TRAITEMENT DE LA FIBROSE ET D'ÉTATS ASSOCIÉS À LA FIBROSE
Heterocyclic compounds with dibenzazapine structures
申请人:Merck Patent GmbH
公开号:US10636979B2
公开(公告)日:2020-04-28
The present invention relates to heterocyclic compounds and electronic devices, in particular organic electroluminescent devices, containing these compounds.
本发明涉及杂环化合物和电子器件,特别是含有这些化合物的有机电致发光器件。
MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
申请人:Merck Patent GmbH
公开号:US20150295186A1
公开(公告)日:2015-10-15
The present invention relates to compounds according to formula (1) and formula (2), said compounds being suitable for use in electronic devices, in particular organic electroluminescent devices.
本发明涉及公式(1)和公式(2)所示的化合物,该化合物适用于电子器件,特别是有机电致发光器件。
Compositions for the treatment of fibrosis and fibrosis-related conditions
申请人:VECTUS BIOSYSTEMS LIMITED
公开号:US10035775B2
公开(公告)日:2018-07-31
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of fibrosis and fibrosis-related conditions.
本发明涉及新型化合物及其在预防和/或治疗纤维化和纤维化相关疾病中的用途。
A New Synthesis of Naphthyridinones and Quinolinones: Palladium-Catalyzed Amidation of <i>o</i>-Carbonyl-Substituted Aryl Halides
作者:Peter J. Manley、Mark T. Bilodeau
DOI:10.1021/ol049165t
日期:2004.7.1
An alternative to the Friedlander condensation for the synthesis of naphthyridinones and quinolinones has been discovered. Palladium-catalyzed amidation of halo aromatics substituted in the ortho position by a carbonyl functional group or its equivalent with primary or secondary amides leads to the formation of substituted naphthyridinones and quinolinones.
MATERIALIEN FÜR ORGANISCHE ELEKTROLUMINESZENZVORRICHTUNGEN